Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort.

OBJECTIVES To describe brain magnetic resonance imaging (MRI) abnormalities in newly diagnosed neuropsychiatric lupus (NPSLE). To correlate them with clinical and laboratory data. METHODS This retrospective cross-sectional study included patients presenting NPSLE undergoing brain MRI within 6 months after onset between 2003 and 2012. Clinical and laboratory data were recorded. MRI findings were defined as inflammatory-like, large-vessel disease (LVD), and small-vessel disease (SVD); SVD was classified as white-matter hyperintensities (WMH), recent small subcortical infarcts, lacunes, microbleeds, and brain atrophy. RESULTS We included 108 patients (mean 40.6 ± 14.2 years; range 14-77), 91.7% women. The most frequent syndromes were headache (28.5%), cerebrovascular disease (15.5%), seizure (15.5%), and cognitive dysfunction (11.4%). Brain abnormalities were found in 59.3%. SVD was the most common (55.6%), followed by LVD (13%) and inflammatory-like lesions (6.5%). The most frequent SVD findings were WMH (53.7%), atrophy (18.5%), microbleeds (13.7%) and lacunes (11.1%). Cerebrovascular syndrome correlated with LVD (p = 0.001) and microbleeds (p = 0.002), cognitive dysfunction with WMH (p = 0.045) and myelopathy with inflammatory-like lesions (p = 0.020). Low C4 and CH50 correlated with inflammatory-like lesions (p < 0.001, p = 0.019) and lupus anticoagulant with WMH (p = 0.018), microbleeds (p = 0.002) and atrophy (p = 0.008). CONCLUSIONS Vascular disease is the hallmark of NPSLE. Certain syndromes and immunological patterns are prone to more extensive brain damage. MRI could provide significant clinical information and insights into the pathological substrate.

[1]  J. L. Cox,et al.  Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement , 2013, Lupus.

[2]  K. Sawanyawisuth,et al.  Clinical features and predictive factors in neuropsychiatric lupus. , 2012, Asian Pacific journal of allergy and immunology.

[3]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[4]  L. Csiba,et al.  MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension , 2003, Journal of Neurology.

[5]  H. Petropoulos,et al.  Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[6]  J. Ioannidis,et al.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs , 2010, Annals of the rheumatic diseases.

[7]  Núria Bargalló,et al.  Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. , 2013, Autoimmunity reviews.

[8]  I. Bruce,et al.  Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[9]  G. Hughes,et al.  Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.

[10]  Andreas Charidimou,et al.  Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings , 2013, Neuroradiology.

[11]  M. van Buchem,et al.  Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause , 2012, Annals of the rheumatic diseases.

[12]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[13]  P. Szewczyk,et al.  In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging , 2014, Lupus.

[14]  F Barkhof,et al.  Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.

[15]  Simone Appenzeller,et al.  Magnetic Resonance Imaging in the Evaluation of Central Nervous System Manifestations in Systemic Lupus Erythematosus , 2008, Clinical reviews in allergy & immunology.

[16]  G. Loheswaran,et al.  Altered neuroendocrine status at the onset of CNS lupus-like disease , 2013, Brain, Behavior, and Immunity.

[17]  N. Scolding,et al.  CNS lupus , 2007, Neurology.

[18]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[19]  Li Min Li,et al.  Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus , 2007, NeuroImage.

[20]  W. Brooks,et al.  Neuroimaging in neuropsychiatric systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[21]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[22]  R. Fonseca,et al.  Neuropsychiatric Lupus: Classification Criteria in Neuroimaging Studies , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[23]  M. Govoni,et al.  Optimizing clinical monitoring of central nervous system involvement in SLE. , 2008, Autoimmunity reviews.

[24]  D. Boumpas,et al.  Pathogenesis and treatment of CNS lupus , 2013, Current opinion in rheumatology.

[25]  A. Afeltra,et al.  Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis. , 2014, Autoimmunity reviews.

[26]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[27]  R. Brey Antiphospholipid Antibodies in Young Adults with Stroke , 2005, Journal of Thrombosis and Thrombolysis.

[28]  Li Min Li,et al.  Cerebral and corpus callosum atrophy in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[29]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[30]  P Dastidar,et al.  Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study , 2005, Scandinavian journal of rheumatology.

[31]  S. Baldovino,et al.  Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. , 2013, Autoimmunity reviews.

[32]  D. Boumpas,et al.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations , 2010, Nature Reviews Rheumatology.

[33]  M. Piga,et al.  Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations , 2000, Lupus.

[34]  M. Boaz,et al.  Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. , 2011, Seminars in arthritis and rheumatism.

[35]  B. Hart,et al.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.

[36]  M. van Buchem,et al.  Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. , 2011, Arthritis and rheumatism.

[37]  I. Bruce,et al.  Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. , 2013, Arthritis and rheumatism.

[38]  L. Costallat,et al.  Cerebral Atrophy Related to Corticotherapy in Systemic Lupus Erythematosus (SLE) , 2001, Clinical Rheumatology.

[39]  B. Nan,et al.  Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain , 2007, Acta radiologica.

[40]  R. Cervera,et al.  Systemic lupus erythematosus. , 2010, Best practice & research. Clinical rheumatology.

[41]  Tobias Schmidt-Wilcke,et al.  Changes in Regional Brain Morphology in Neuropsychiatric Systemic Lupus Erythematosus , 2012, The Journal of Rheumatology.

[42]  S. Muller,et al.  Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. , 2014, Autoimmunity reviews.

[43]  Li Min Li,et al.  Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients , 2008, Annals of neurology.

[44]  S. Cessie,et al.  Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE) , 2014, Lupus.

[45]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[46]  Peter T Fox,et al.  Brain Magnetic Resonance Imaging in Newly Diagnosed Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[47]  F. Jennekens,et al.  The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. , 2002, Rheumatology.